Performance Evaluation Study for a New Meconium Detection Test

Laniado Hospital100 enrolled

Overview

The purpose of this study is to collect amniotic fluid samples from pregnant women. Amniotic fluid samples will be tested for meconium with a new assay. The results will be correlated with other laboratory tests.

Female volunteers will be recruited locally in a single medical center. After the occurrence of amniotic membranes rupture, amniotic fluid samples will be collected extracorporeally. Meconium concentration levels will be measured by the new test. Other laboratory tests will be employed in order to determine the accuracy of the new test.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Pregnancy

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 50 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Provide written or oral informed consent to participate in the study and agree to comply with study procedures. * Pregnant. * Intend to seek medical care during pregnancy. Exclusion Criteria: * Amniotic fluid samples are mixed with urine.

Locations (1)

Laniado Hospital

Netanya, Israel

RECRUITING

Outcomes

Primary Outcomes

Meconium concentration in amniotic fluid

Time frame: One year

Central Contacts

Brigita Weitrov, MD

CONTACT

972-50-8840757 morami12@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.